COLUMNS by Moira Dower



Moira Dower is a freelance writer/editor on healthcare and pharmaceutical issues.

She was formerly Editor of Scrip World Pharmaceutical News and Managing Editor of Scrip Magazine.

Please reload

September 14, 2020

Six months ago, as most countries began lockdown in an attempt to control the coronavirus pandemic, critics of big pharma were suggesting that companies would put profits before philanthropy and look to make a ’fast buck’ out of a worldwide health crisis (see April-Jun...

April 1, 2020

Like toilet roll profiteers, some (pharma firms) are failing to share all of the data on potential candidate treatments that they hold … they are keeping it stashed in their digital attics and cellars where others cannot get at it, on the grounds that it is commercial...

December 5, 2019

Despite evidence of the pharma industry’s R&D pipeline continuing to generate a stream of breakthrough new medicines for unmet medical needs, its reputation appears to have reached a new low.

Pharma’s reputation has sunk to “new low”, according to a recent Gallup poll....

September 4, 2019

Concern about high prices for new breakthrough medicines is prompting a push for greater transparency on pricing and reimbursement, with growing demand for the sharing of information on actual market (net) prices in a way that threatens the confidentiality of the prici...

Please reload

Featured Posts

Healthcare in Crisis – What Can Pharma Do?

March 6, 2018

Please reload

Recent Posts

December 5, 2019

July 16, 2019

Please reload